Newsroom
FDA approves Spark Therapeutics’ retinal disease gene therapy Luxturna, a month ahead of schedule
Interface of retinal pigment epithelium and photoreceptor cells. Source: NIH Open-i As we discussed in our December 17, 2015…
Understanding Drug Interactions and Medication Safety
Medication safety is a critical issue in healthcare. One of the most common and potentially dangerous risks patients face is…
⚖️ Regaining Your Balance & Keeping It
⚖️ Regaining Your Balance & Keeping It Every veterinary professional knows what it feels like to chase balance and come…
Preparing Cincinnati Manufacturing Facilities for Fall With Reliable Water Purification
As the seasons change in Cincinnati, manufacturers face new challenges in…
Executive Brief: Compliant Targeting Ailment-Specific…
Compliant Targeting Ailment-Specific Audiences The Challenge: Healthcare and pharmaceutical companies face a critical challenge: reaching consumers actively researching specific ailments or…
Webinar: Building the leadership teams that launch in Europe
Leaders that Launch In this webinar, we will look at the key success factors to biotech leadership hiring by unpacking…